Physician

Jasmine Gowarty

According to 2025 Medicare claims, Jasmine Gowarty (NPI: 1003263732) practices hematology/oncology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 78503-1271.

Gowarty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 276 traditional Medicare patients, billed 39,843 HCPCS/CPT codes, and received $531,859 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 336 prescription claims across 93 beneficiaries totaling $533,248 in drug costs, led by Abiraterone Acetate (Abiraterone Acetate). 2022 DME data shows 22 claims. Open Payments data shows 17 records totaling $612. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $13,588 to $531,859. Similarly, Part D prescription costs have moved sharply higher in recent years, from $262 to $533,248. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	97	164	$13,588
2020	46	68	$4,686
2021	13	13	$684
2022	13	13	$711
2023	125	15,283	$199,421
2024	276	39,843	$531,859

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	24	$262
2017	24	86	$2,392
2018	42	129	$9,896
2019	60	175	$8,378
2020	39	115	$22,777
2021	39	142	$482,883
2022	56	157	$419,075
2023	21	67	$88,783
2024	93	336	$533,248

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	22	$1,188
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	78	126	$89
80053	Blood test, comprehensive group of blood chemicals	78	205	$10
36415	Insertion of needle into vein for collection of blood sample	83	248	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	82	233	$8
83615	Lactate dehydrogenase (enzyme) level	53	63	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Abiraterone Acetate	Abiraterone Acetate	11	330	$21,651
Imatinib Mesylate	Imatinib Mesylate	12	360	$869
Anastrozole	Anastrozole	26	1,786	$496
Lidocaine-Prilocaine	Lidocaine/Prilocaine	16	460	$242
Hydroxyurea	Hydroxyurea	22	776	$213

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$612	Sirtex Medical Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jasmine Gowarty?

Tedicare shows public-source Medicare data for Jasmine Gowarty (NPI 1003263732), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jasmine Gowarty have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jasmine Gowarty?

Jasmine Gowarty is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Jasmine Gowarty have Open Payments data?

Jasmine Gowarty has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.